Concord Biotech Limited (BOM:543960)
India
· Delayed Price · Currency is INR 1,404.05
+1.00 (0.07%)
At close: Dec 5, 2025
Concord Biotech Revenue
Concord Biotech had revenue of 2.47B INR in the quarter ending September 30, 2025, a decrease of -20.35%. This brings the company's revenue in the last twelve months to 11.25B, up 3.63% year-over-year. In the fiscal year ending March 31, 2025, Concord Biotech had annual revenue of 12.00B with 18.01% growth.
Revenue (ttm)
11.25B
Revenue Growth
+3.63%
P/S Ratio
13.10
Revenue / Employee
7.16M
Employees
1,571
Market Cap
147.34B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,996.29B |
| HDFC Bank | 2,683.70B |
| Bharti Airtel | 1,946.14B |
| Tata Consultancy Services | 2,576.88B |
| ICICI Bank | 1,909.34B |
| State Bank of India | 3,571.95B |
| Infosys | 1,748.84B |
| Bajaj Finance | 406.39B |